Your browser doesn't support javascript.
loading
Prophylactic Steroids for Preventing Postembolization Syndrome after Transcatheter Arterial Embolization of Renal Angiomyolipoma: A Comparative Study.
Tsuchiya, Satoshi; Saiga, Atsushi; Yokota, Hajime; Kubota, Yoshihiro; Wada, Takeshi; Akutsu, Akira; Koizumi, Jun; Aramaki, Takeshi; Uno, Takashi.
Afiliação
  • Tsuchiya S; Division of Interventional Radiology, Shizuoka Cancer Center, Japan.
  • Saiga A; Department of Radiology, Chiba University Hospital, Japan.
  • Yokota H; Division of Interventional Radiology, Shizuoka Cancer Center, Japan.
  • Kubota Y; Department of Radiology, Chiba University Hospital, Japan.
  • Wada T; Department of Diagnostic Radiology and Radiation Oncology, Chiba University Graduate School of Medicine, Japan.
  • Akutsu A; Department of Radiology, Chiba University Hospital, Japan.
  • Koizumi J; Department of Radiology, Chiba University Hospital, Japan.
  • Aramaki T; Department of Radiology, Chiba University Hospital, Japan.
  • Uno T; Department of Radiology, Chiba University Hospital, Japan.
Interv Radiol (Higashimatsuyama) ; 8(1): 1-6, 2023 Mar 01.
Article em En | MEDLINE | ID: mdl-36936258
ABSTRACT

Purpose:

Postembolization syndrome (PES) after renal arterial embolization (RAE) can reduce the patient's tolerance of the procedure and extend the length of hospital stay. We aimed to assess the efficacy of steroid administration in preventing PES in patients undergoing RAE for angiomyolipoma (AML). Material and

Methods:

Between May 2004 and March 2020, 29 RAE procedures in 26 patients with AML were performed. Patient information, including age, sex, tumor size, tuberous sclerosis complex-associated/sporadic AML, hemorrhagic/nonhemorrhagic AML, embolic material, steroid use, medication type, some blood laboratory parameters, hospital stay, and PES occurrence were retrospectively obtained. The prophylactic steroid protocol used in the study was as follows 250 mg of intravenous methylprednisolone (Solu-Medrol) 2 h before the RAE procedure, followed by 2 days of intravenous prednisolone (Predonine; 2 mg/kg/day), which was tapered by halving the dose every 2 days within the course of 2 weeks. After the discharge, intravenous prednisolone was changed to oral prednisolone (Predonine). PES was defined as the presence of fever, pain, nausea, or vomiting. Data were compared between the steroid and non-steroid groups and between PES and non-PES groups.

Results:

The PES incidence rate was 76%, and a comparison between the steroid and non-steroid groups revealed that steroid use significantly decreased the incidence of PES (P < 0.001), including fever (P < 0.001), pain (P = 0.005), and nausea (P = 0.028). The use of anti-inflammatory drugs during the hospital stay was significantly lower in the steroid group (P = 0.019). Moreover, in the steroid group, C-reactive protein level was significantly lower (P = 0.006), whereas white blood cell count was significantly higher (P = 0.004). Conversely, the median length of hospital stay was not significantly shorter in the steroid group (P = 0.292).

Conclusions:

The prophylactic use of steroids before and after embolization of renal AML may be effective in preventing PES in this small retrospective study.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Interv Radiol (Higashimatsuyama) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Interv Radiol (Higashimatsuyama) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão